Clinical Trial Update: Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse

View source ↗

Summary

The clinical trial NCT05042453 evaluating the long-term efficacy and safety of Splentis for primary apical pelvic organ prolapse is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Drugs mentioned

• Splentis

Snippet

Sponsor: Promedon | Conditions: Pelvic Organ Prolapse | Status: RECRUITING